Dr. Lynch presents on the use of Pembrolizumab for Hodgkin's lymphoma patients at ASH 2021

SCCA's Dr. Ryan C. Lynch presents his poster, Concurrent Pembrolizumab with AVD for Untreated Classical Hodgkin Lymphoma at the 63rd ASH Annual Meeting and Exposition. Learn more about SCCA's appearance at ASH 2021 at https://www.seattlecca.org/conference/ash-2021

• Categoria